Trial Profile
Effect of Cilostazol as an add-on Treatment to a Single Antiplatelet Agent (Acetylsalicylic Acid or Clopidogrel) on Platelet Function Testing and Bleeding Time in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 Oct 2021
Price :
$35
*
At a glance
- Drugs Cilostazol (Primary) ; Aspirin; Clopidogrel
- Indications Angina pectoris; Arterial occlusive disorders; Coronary artery restenosis; Intermittent claudication; Stroke
- Focus Therapeutic Use
- Acronyms CiloMecT
- Sponsors Otsuka Pharmaceutical
- 03 Nov 2020 Status changed from active, no longer recruiting to completed.
- 02 May 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
- 02 May 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.